Interleukin-11 (IL-11) enhances clonal proliferation of acute myelogenous leukemia cells with strong expression of the IL-11 receptor α chain and signal transducing gp130

Leukemia

Volumn 13, Issue 7, 1999, Pages 1018-1027

  Kimura, T ^a   Sakabe, H ^b   Minamiguchi, H ^a,b   Fujiki, H ^a   Abe, T ^a   Kaneko, H ^a   Yokota, S ^a   Nakagawa, H ^c   Fujii, H ^c   Tamaki, H ^d   Ogawa, H ^d   Sugiyama, H ^d   Sonoda, Y ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

AML; gp130; IL 11; IL 11 receptor; L CFU

Indexed keywords

COLONY STIMULATING FACTOR; FLT3 LIGAND; GLYCOPROTEIN GP 130; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; CELL CLONE; CELL PROLIFERATION; CELL SELECTION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0032811493     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401433     Document Type: Article

References (49)

1. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM, Leary AC, Sibley B, Clark SC, Williams DA, Yang Y-C. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990; 87: 7512-7516.
2. Romes E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 1996; 183: 2581-2591.
3. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Kato K, Takatsuki K. Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp Hematol 1992; 20: 1011-1016.
4. Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H. Interleukin-11 enhances human megakaryopoiesis in vitro. Blood 1992; 79: 327-331.
5. Weich NS, Wang A, Fitzgerald M, Neben TY, Donaldson D, Giannotti J, Yetz-Aldape J, Leven RM, Turner KJ. Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood 1997; 90: 3893-3902.
6. Kimura T, Sakabe H, Tanimukai S, Abe T, Urata Y, Yasukawa K, Okano A, Taga T, Sugiyama H, Kishimoto T, Sonoda Y. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. Blood 1997; 90: 4767-4778.
7. Musashi M, Yang Y-C, Paul SR, Clark SC, Sudo T, Ogawa M. Direct and synergistic effects of interleukin-11 on murine hemopoiesis in culture. Proc Natl Acad Sci USA 1991; 88: 765-769.
8. Musashi M, Clark SC, Sudo T, Urdal DL, Ogawa M. Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hemopoietic progenitors of mice. Blood 1991; 78: 1448-1451.
9. Quesniaux VFJ, Clark SC, Turner K, Fagg B. Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood 1992; 80: 1218-1223.
10. Hangoc G, Yin T, Cooper S, Schendel P, Yang Y-C, Broxmeyer HE. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 1993; 81: 965-972.
11. Lenard JP, Quinto CM, Kozitza MK, Neben TY, Goldman SJ. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994; 83: 1499-1506.
12. Gordon MS, McCaskill-Stevens, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW. A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996; 87: 3615-3624.
13. Tepler I, Elias L, Smith II JW, Hussein M, Rosen G, Chang AYC, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996; 87: 3607-3614.
14. Hu JP, Santoli CD, Clark SC, Hoang T. Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood 1993; 81: 1586-1592.
15. Lemoli RM, Fogli M, Fortuna A, Amabile M, Zucchini P. Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukemic cells. Br J Haematol 1995; 91: 319-326.
16. Ailles L, Gerhard B, Hogge DE. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood 1997; 90: 2555-2564.
17. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994; 76: 253-262.
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 1985; 103: 626-629.
19. Kobayashi T, Miyawaki S, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K, Ohmoto E, Oh H, Jinnnai I, Sakamaki H, Hiraoka A, Kanamaru A, Takahashi I, Saito K, Naoe T, Yamada O, Asou N, Kageyama S, Emi N, Matsuoka A, Tomonaga M, Saito H, Ueda R, Ohno R for JALSG. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. J Clin Oncol 1996; 14: 204-213.
20. Sonoda Y, Misawa S, Maekawa T, Taniwaki M, Abe T, Takino T. A variant 15;17 translocation in a patient with acute promyelocytic leukemia. Cancer Genet Cytogenet 1985; 17: 61-67.
21. Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also an erythroid and multipotential progenitors in vitro. Exp Hematol 1997; 25: 1025-1033.
22. Takaue Y, Watanabe T, Kawano Y, Koyama T, Abe T, Suzue T, Satoh J, Shimokawa T, Ninomiya T, Kosaka M, Shimizu E, Ogura T, Kuroda Y. Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer. Blood 1989; 74: 1245-1251.
23. Lyman SD, James L, Johnson L, Brasel K, De Vries P, Escobar SS, Downey H, Splett RR, Beckmann P, McKenna HJ. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795-2801.
24. Paul SR, Barut BA, Bennett F, Cochran MA, Anderson KC. Lack of a role of interleukin 11 in the growth of multiple myeloma. Leukemia Res 1992; 16: 247-252.
25. Cherel M, Sorel M, Lebeau B, Dubois S, Moreau J-F, Bataille R, Minvielle S, Jacques Y. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 1995; 86: 2534-2540.
26. Kobayashi S, Teramura M, Sugawara I, Oshimi K, Mizoguchi H. Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood 1993; 81: 889-893.
27. Stacchini A, Fubini L, Severino A, Sanavio F, Aglietta M, Piacibello W. Expression of type III receptor tyrosine kinases flt3 and kit and response to their ligands by acute myeloid leukemia blasts. Leukemia 1996; 10: 1584-1591.
28. Hirakawa K, Kimura S, Chikayama S, Misawa S, Maekawa T. Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors. Leukemia 1996; 10: 279-287.
29. Buick RN, Minden MD, McCulloch EA. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 1979; 54: 95-104.
30. Nara N, Curtis JE, Senn JS, Tritchler DL, McCulloch EA. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Blood 1986; 67: 762-769.
31. + highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein. Blood 1994; 84: 4099-4106.
32. - cells: correlation between long-term culture-initiating cells and telomerase expression. Leukemia 1997; 12: 728-734.
33. Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis M, Shoyab M, Yancopoulos GD, Kishimoto T. Functional inhibition of hematopoietic and neurotropic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 1992; 89: 10998-11001.
34. Misawa N, Ohnishi T, Itoh K, Takahashi E. Development of a tissue culture assay system for Campylobacter jejuni cytotoxin and the influence of culture conditions on cytotoxin production. J Med Microbiol 1994; 41: 224-230.
35. Nara N, Kurokawa H, Tanikawa S, Tomiyama J, Nagata K. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia. Cancer 1994; 73: 92-97.
36. Murohashi I, Tohda S, Suzuki T, Nagata K, Yamashita Y, Nara N. Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia. Blood 1989; 74: 35-41.
37. Griffin JD, Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185-1195.
38. Lowenberg B, Touw IP. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281-292.
39. Aoyama K, Uchida T, Takanuki F, Usui T, Watanabe T, Higuchi S, Toyoki T, Mizoguchi H. Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects. Br J Clin Pharmacol 1997; 43: 571-578.
40. Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, Kamachi S. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989; 73: 117-122.
41. Takahashi S, Asano S. An open study of recombinant granulocyte colony-stimulating factor (lenograstim) administered subcutaneously for neutropenia in acute lymphocytic leukemia. Biotherapy 1997; 11: 923-929.
42. Baiocchi G, Scambia G, Benedetti P, Menichella G, Testa U, Pierelli L, Martucci R, Foddai ML, Bizzi B, Mancuso S, Peschle C. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery. Cancer Res 1993; 53: 1297-1303.
43. Haas R, Gericke G, Witt B, Cayeux S, Hunstein W. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation. Exp Hematol 1993; 21: 109-113.
44. Inoue K, Sugiyama H, Ogawa H, Yamagami T, Azuma T, Oka Y, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Hara J, Kanamaru A, Kishimoto T. Expression of interleukin-6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia. Blood 1994; 84: 2672-2680.
45. Ohno R, Kobayashi T, Tanimoto M, Hiraoka A, Imai K, Asou N, Tomonaga M, Tsubaki K, Takahashi I, Kodera Y, Yoshida M, Murakami H, Naoe T, Shimoyama M, Tsukada T, Takeo T, Teshima H, Onozawa Y, Fujimoto K, Kuriyama K, Horiuchi A, Kimura I, Minami S, Miura Y, Kageyama S, Tahara T, Masaoka T, Shirakawa S, Saito H. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. Cancer 1993; 71: 3888-3895.
46. Appelbaum FR, Kopecky KJ. Long-term survival after chemotherapy for acute myeloid leukemia. Cancer 1997; 80: 2199-2204.
47. Zittoun RA, Mandelli F, Willemze R, Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotolli B, Leoni P, Peeteemans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
48. Tafuri T, Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 1990; 4: 826-834.
49. McCulloch EA, Curtis JE, Messner HA, Senn JS, Germanson TP. The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). Blood 1982; 59: 601-608.